Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
Aims: Cisplatin is a frontline chemotherapeutic utilized to attenuate multiple cancers in the clinic. Given its side -effects, a new cisplatin formulation which could prevent cytotoxicity, metabolic deficiencies and metastasis is much needed. This study investigates whether nanocarriers can provide...
Saved in:
Main Authors: | Ranasinghe, Ranmali, Mathai, Michael, Alshawsh, Mohammed Abdullah, Zulli, Anthony |
---|---|
Format: | Article |
Published: |
Elsevier
2024
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/45315/ https://doi.org/10.1016/j.heliyon.2024.e28171 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Smart stimuli-responsive nanocarriers for the cancer therapy - nanomedicine
by: Murugan, Baranya, et al.
Published: (2021) -
Gene therapy in oral cancer: a promising prospect
by: Arief Ichwan, Solachuddin Jauhari
Published: (2016) -
Chitosan-modified nanocarriers as carriers for anticancer drug delivery: promises and hurdles
by: Alhodieb, Fahad Saad, et al.
Published: (2022) -
Potential implications of GRP58 expression and susceptibility of cervical cancer to cisplatin and thymoquinone-based therapy
by: Wan Abd Ghani, Wan Nor Hafiza, et al.
Published: (2014) -
Doxorubicin Loading on Functional Graphene as a Promising Nanocarrier Using Ternary Deep Eutectic Solvent Systems
by: Zainal-Abidin, Mohamad Hamdi, et al.
Published: (2020)